Infectopyoderm

Mupirocin, the active ingredient in Infectopyoderm, is an antibiotic presented as a topical preparation for cutaneous use. It treats bacterial skin infections such as impetigo, infected eczema and minor wound infections in patients of all ages. It is commonly prescribed for localized infections and is valued for its low systemic absorption.

GNH USA supplies Infectopyoderm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with established logistics and regulatory expertise across EU and global markets.

Mupirocin is used to treat bacterial skin infections by targeting the causative organisms.

- Impetigo: Reduces bacterial load and promotes healing of superficial skin lesions. - Infected eczema (dermatitis): Controls secondary bacterial infection and alleviates inflammation. - Minor wound infections: Prevents bacterial proliferation and supports tissue repair.

Mupirocin may cause local skin reactions and, rarely, systemic allergic responses.

Common Side Effects: - Local irritation: mild burning or stinging at the application site. - Itching: transient pruritus around the treated area. - Redness: erythema of the skin.

Serious or Rare Side Effects: - Contact dermatitis: severe allergic skin reaction with swelling and vesicles. - Anaphylaxis: rare systemic allergic reaction with difficulty breathing. - Stevens‑Johnson syndrome: extremely rare severe mucocutaneous reaction.

When using Infectopyoderm, consider the following precautions to ensure safe and effective treatment.

- Avoid extensive application: limit use to small affected areas to reduce systemic absorption. - Known hypersensitivity: do not use if the patient has a documented allergy to mupirocin or other topical antibiotics. - Concomitant corticosteroids: monitor for masked infection signs when used with topical steroids. - Pediatric use: exercise caution in infants and young children; consult a healthcare professional. - Storage: Store at room temperature: keep in the original container, protect from moisture and light.

Topical mupirocin has limited systemic drug interactions, but certain combinations may affect its safety or efficacy.

Major Interactions (Avoid): - Concurrent use with other topical antibiotics (e.g., fusidic acid) may increase risk of bacterial resistance. - Application over ocular surfaces: avoid combining with eye medications as mupirocin is not approved for ocular use.

Moderate Interactions (Monitor Closely): - Use with topical corticosteroids may diminish visible signs of infection; monitor clinical response. - Co‑application with silver‑containing dressings may reduce antibacterial activity. - Systemic antibiotics targeting the same organisms may be unnecessary; assess need for combined therapy.